Chemical.AI announced a partnership with Pfizer to create AI-driven pharmaceuticals
Chemical.AI has been profoundly engaged in the field of artificial intelligence and big data, providing a creative way to boost the efficiency of new drug research and development for customers. Together with Pfizer, we have applied the ChemAIRS—AI-Powered Retrosynthesis Routes Design Platform to their new drugs development process.
Dr. Ning Xia, the founder and CEO of Chemical.AI, stated, “With the rapid advancement of artificial intelligence technology, AI in pharmaceuticals can help pharmaceutical enterprises in accelerating the pace of new drug research and development, achieving cost reduction and efficiency enhancement. Since its establishment, Chemical.AI has been committed to promote the development of AI in pharmaceuticals. We are delighted to collaborate with Pfizer and we will persist in adhering to our original aspiration—to shape the future of chemistry.”
Chemical.AI established the comprehensive ChemAI Solution system in 2022, with its core business segmented into four major components: ChemAIRS, ChemAIOS, and ChemAIoT.
ChemAIRS
Based on chemical big data mining and deep learning algorithms, ChemAIRS can design multiple synthetic routes for a target molecule within a few minutes, fully considering factors like reaction feasibility, functional group compatibility, chiral synthesis strategies, etc., providing chemists diverse viable synthetic ideas.
ChemAIOS
ChemAIOS Intelligent Lab Management System is an AI-empowered, fully digitalized lab management system independently developed by Chemical.AI. It helps standardize lab workflows, enable data closed-loop, and enhance R&D efficiency to build the lab data ecosystem of the future.
ChemAIoT
Connecting collaborative robots with various equipments, non-standard customized modules, and combining with AI and life sciences and automation, to provide AI + IoT integrated solutions for chemistry, inspection and testing, biology, healthcare, etc，which to achieve intelligentization of the entire experiment process.
About Chemical.AI
Founded in 2018, Chemical.AI leads the innovation in chemical synthesis through AI and automation. We work with over 100 companies and research institutes to enhance chemical synthesis strategies, processes, and productivity by integrating proprietary retrosynthesis algorithms, comprehensive chemical data, and state-of-the-art robotic lab automation. Our goal is to provide advanced cheminformatics and automated solutions across diverse sectors such as pharmaceuticals, materials, biomedicine, and chemical engineering.